AlphaRose Therapeutics

Austin, United States

AlphaRose Therapeutics develops precision medicine for genetic diseases, focusing on autism and neuro-genetic disorders.

$1.7M raised

Jul 2025

Equity Crowdfunding

Biotechnology Medical Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AlphaRose Therapeutics

How much funding has AlphaRose Therapeutics raised?

AlphaRose Therapeutics has raised $1.7M in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in July 2025.

Where is AlphaRose Therapeutics headquartered?

AlphaRose Therapeutics is headquartered in Austin, United States.

What does AlphaRose Therapeutics do?

AlphaRose Therapeutics develops precision medicine for genetic diseases, focusing on autism and neuro-genetic disorders.

What stage is AlphaRose Therapeutics at?

AlphaRose Therapeutics is at the Equity Crowdfunding stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 1, 2025.

MLA

"AlphaRose Therapeutics — Funding & Investors." VCBacked, July 1, 2025, https://www.vcbacked.co/company/alpharose-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2025). AlphaRose Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/alpharose-therapeutics

Wikipedia (cite web)

{{cite web |title=AlphaRose Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/alpharose-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 1, 2025.